What is ‘Implementation Science’?
How do we leverage partnerships with industry to ensure throughout adoption of #ESCGuidelines at all levels of patient daily care?
#ESCardioCRT continues its strategic discussions on #ESCGuidelines implementation- focusing on concrete solutions for reducing the ‘evidence-practice’ gap.
Stay tuned for our coverage over the next couple of days.
Exciting conversation arround the 3R : Right therapy for the Right patient at the Right Time, Cardiac Rythm devices are cornestones in heart failure management @hvanspall@AlexMebazaa Thank you
What's new in heart failure clinical trials? Mariell Jessup (@MariellJessup) and Harriette Van Spall (@hvanspall) share thoughts on emerging therapies and innovations in HF care from THT 2024 sessions.
https://t.co/1qdKYOsQkZ
🔺There is no high-quality evidence to support use of #BetaBlockers in #HFpEF https://t.co/jYfTPnGUiR
🔺In absence of other indications, consider withdrawing BBs from HFpEF regimen, especially in setting of #chronotropic incompetence (ie chronotropic index <0.62 during max #CPET)
We offer low cost, virtual pacemaker education to generate opportunities for those who don't have them.....
We help Place people in the Pacemaker industry.....
We're a Placemaker company.
#EPeeps#CardioTwitter#DiversityandInclusion#Cardiology